Engineering of the genetic code.
Level 5 - mechanism / opinion, no new human data
Narrative review of molecular engineering methods without primary human clinical data (graded by design analogy).
PubMed 39733656 · doi:10.1016/j.copbio.2024.103245
What was done
This narrative review summarizes recent strategies in genetic code expansion, focusing on nucleotide modification, codon reassignment, genome-wide recoding, synthetic base pair introduction, and the engineering of orthogonal translational machinery to incorporate noncanonical amino acids into proteins.
What was found
The abstract reports no numerical values, effect sizes, or quantitative metrics. It summarizes qualitative advances in expanding protein chemistries (e.g., adding bio-orthogonal handles, fluorophores, and redox-active groups) while addressing challenges related to translational efficiency and off-target effects.
Why it matters
Genetic code expansion enables the site-specific introduction of custom chemical functionalities into proteins, providing foundational tools for synthetic biology, molecular imaging, and protein-based therapeutics.
Limits
The abstract describes a narrative review without primary data or a systematic search methodology. It provides no quantitative comparisons of incorporation efficiency, fidelity, off-target rates, or cell viability across different expression platforms.
Cited by
- supports In the standard genetic code, there are 64 triplet codons, and AAA codes for the amino acid lysine.